The idea that MMTV is involved in human breast cancer has been around for over 50 years. In the 1990s, researchers detected MMTV in human breast tumors, but not in healthy breast tissue. The link between MMTV and human breast cancer was contentious though, as some scientists believed the presence of MMTV in tumors was caused by contamination rather than infection.
However, two years ago, researchers from the University of Veterinary Medicine, Austrianova Biotechnology and the Christian-Doppler Laboratory for Gene Therapeutic Vector Development, all based in Vienna, Austria, showed that MMTV does actually infect human cells.
Now, they have added to these findings with this latest study, which shows that MMTV can replicate in cultured human breast cells. The new virus particles produced by the infected cells enabled the virus to spread rapidly, leading to the infection of every cell in culture.
"It has recently been shown convincingly that MMTV can infect human cells. Often, however, viruses infect cells but cannot replicate further. If they can replicate, the chances that they cause disease may be increased," says Dr Stanislav Indik from the University of Veterinary Medicine, Vienna and one of the study's authors.
There are a number of questions still to be answered before a concrete role of MMTV in human breast cancer is established, including whether MMTV can infect primary cells - those taken directly from the body, not from a cultured cell line. Also, researchers plan to investigate how the virus spreads from mice to humans, and to examine if one of the possible outcomes of human MMTV infection is breast cancer.
MMTV is a retrovirus, the same kind of virus as HIV. If MMTV is eventually found to play a role in human breast cancer, current treatments for HIV may also be effective against MMTV.
Helping to Transport Proteins Inside the Cell
21.11.2018 | Albert-Ludwigs-Universität Freiburg im Breisgau
UNH researchers create a more effective hydrogel for healing wounds
21.11.2018 | University of New Hampshire
Innsbruck quantum physicists have constructed a diode for magnetic fields and then tested it in the laboratory. The device, developed by the research groups led by the theorist Oriol Romero-Isart and the experimental physicist Gerhard Kirchmair, could open up a number of new applications.
Electric diodes are essential electronic components that conduct electricity in one direction but prevent conduction in the opposite one. They are found at the...
Max Planck researchers revel the nano-structure of molecular trains and the reason for smooth transport in cellular antennas.
Moving around, sensing the extracellular environment, and signaling to other cells are important for a cell to function properly. Responsible for those tasks...
Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.
Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...
Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.
Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...
Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.
In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...
19.11.2018 | Event News
09.11.2018 | Event News
06.11.2018 | Event News
21.11.2018 | Life Sciences
21.11.2018 | Power and Electrical Engineering
21.11.2018 | Life Sciences